ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 281 filers reported holding HAEMONETICS CORP in Q4 2018. The put-call ratio across all filers is 2.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$21,070
-63.1%
235,204
-65.0%
0.02%
-63.8%
Q2 2023$57,145
+4.5%
671,185
+1.5%
0.07%
-2.8%
Q1 2023$54,702
+10.9%
661,048
+5.4%
0.07%
+2.9%
Q4 2022$49,339
-99.6%
627,318
+262.9%
0.07%
+263.2%
Q3 2022$12,797,000
+483.0%
172,859
+413.3%
0.02%
+533.3%
Q2 2022$2,195,000
-49.7%
33,678
-14.3%
0.00%
-50.0%
Q1 2021$4,363,000
+1480.8%
39,300
+1588.1%
0.01%
Q4 2020$276,000
-98.1%
2,328
-98.6%
0.00%
-100.0%
Q3 2020$14,327,000
-22.7%
164,202
-20.6%
0.02%
-32.4%
Q2 2020$18,533,000
+761.6%
206,933
+1057.8%
0.03%
+580.0%
Q2 2019$2,151,000
-0.0%
17,873
-27.3%
0.01%0.0%
Q1 2019$2,152,000
-90.0%
24,600
-86.9%
0.01%
-89.8%
Q3 2018$21,524,000
-45.4%
187,848
-57.2%
0.05%
-49.0%
Q2 2018$39,395,000
+542.0%
439,282
+423.8%
0.10%
+585.7%
Q1 2018$6,136,000
-11.7%
83,870
-45.8%
0.01%
-26.3%
Q3 2017$6,949,000
+13.6%
154,861
+0.0%
0.02%0.0%
Q2 2017$6,115,000154,8560.02%
Other shareholders
HAEMONETICS CORP shareholders Q4 2018
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders